Phoebe Crammond

Phoebe Crammond

Auto-generated profile, based on publicly available information

Phoebe Crammond

Immunovirology and Pathogenesis Program, Kirby Institute, University of New South Wales, Sydney, Australia

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
PHPriyanka Hastak
Priyanka Hastak
CAChristopher R. Andersen
Christopher R. Andersen
PCPhoebe Crammond
Phoebe Crammond
ZZZong-Hong Zhang
Zong-Hong Zhang
CPChansavath Phetsouphanh
Chansavath Phetsouphanh
SSSarah C. Sasson
Sarah C. Sasson
Acute lung injury (ALI) is characterised by hypoxia and inflammation that derives from diverse aetiologies. Delineating the molecular pathogeneses may identify treatable subgroups and inform clinical trials. Using a multi-omics approach, we analysed trauma-associated ALI (n = 9), COVID-19 ALI (n = 11), ICU controls (n = 13) using scRNA-seq, serum cytokine profiling, and bronchoalveolar lavage (BAL) microbiome analysis. We identified a population of activated CD4+ T cells expressing Toll-like receptor 4 (TLR4) and downstream NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome complex, predominantly in trauma-associated ALI (23% of CD45+ Cells) compared to COVID-19 ALI (14%) and ICU controls (15%). Serum IL-1RA and IL-6 were upregulated in trauma ALI, along with TLR4-binding ligand hyaluronan. TLR4 expression on CD4+ T cells was confirmed by spectral cytometry. Lung microbiome analysis revealed distinct diversity in trauma-associated ALI compared to COVID-19 ALI. These findings highlight TLR4-mediated inflammation in trauma-associated ALI and suggest potential precision medicine approaches for ALI management.